Alan B. Lancz & Associates, Inc. Organon & Co. Transaction History

Alan B. Lancz & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$21.42 - $32.08 $214 - $320	10 Added 0.14%	7,224 $169,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $7,915 - $9,725	-250 Reduced 3.35%	7,214 $229,000
Q4 2021 Apr 13, 2022	SELL	$28.67 - $37.13 $717,036 - $928,621	-25,010 Reduced 77.02%	7,464 $227,000
Q4 2021 Feb 09, 2022	BUY	$28.67 - $37.13 $931,029 - $1.21 Million	32,474 New	32,474 $989,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.